ppt

1. COPD
ROLL NO: 17Q0705

2. SUBJECTIVE EVIDENCE
Patient Details:
 Name – Venkataswamy
 Age- 76yrs
 Sex - Male
 IP No. - 10211
 Department – Pulmonary Medicine
 D.O.A – 01/11/21

3. • Reason for admission:
C/o Cold since 3 days,
{breathlessness, Cold/Cough, mild Fever,
Giddiness} since one month.
• Past medical history:
K/C/o COPD since 4 years and not on
Rx.
No h/o HTN/DM/IHD.
• Past medication history:
NIL
• Social history : Chronic smoker.

4. OBJECTIVE EVIDENCE
1. LABORATORY INVESTIGATIONS:
DATE 0I/11 02/11 03/11 05/11 06/11
BP 130/80 130/80 120/80 120/80 110/90

5. 2.BLOOD SUGAR TEST :
R.B.S – 84mg/dL (90-110)

6. 3. BLOOD COUNT:
• Haemoglobin – 13.9g/dL (male 13.5-17.5)
(Female 12-15.5)
• Platelets – 2.01 lakhs (1-3)
• TLC – 9500 cells/cumm (5000-10000)
Different leukocyte count(%)
• Polymorphs(40-60) – 53
• Lymphocytes(20-30) – 41
• Basophils(0-1) – 0
• Eosinophils(1-4) – 1
• Monocytes(1-2) – 5

7. 4.RENAL FUNCTION TESTS:
i)Urea – 27mg% (15-45)
ii)Sr.Creatinine – 1.1mg% (0.6-1.4)

8. 5.URINE EXAMINATION :
Colour – Pale yellow
Pus cells – 2-3
Epithelial cells – 4-5

9. 6.OTHER INVESTIGATIONS:
Sputum c/s, X-ray P.A, ECG.

10. ASSESSMENT
From the subjective and objective evidence
the patient was assessed with
“ACUTE EXACERBATION OF COPD WITH
UPPER RESPIRSTORY TRACT INFECTION”

11. GOALS OF TREATMENT
• Releive symptoms
• Prevent disease progression
• Prevent and treat complications
• To provide better patient care.
• To improve quality of life.

12. TREATMENT CHART
Sl.
no
Drugs with Trade
Name
Drugs with Generic Name Freq Dose Duration
01 Inj.Ceftriaxone Ceftriaxone 1-0-1 1g 1/11 – 9/11
02 Inj.Pantoprazole Pantoprazole 1-0-1 40mg 1/11 – 3/11
03 Tab.Azee Azithromycin 1-0-0 500mg 1/11 – 3/11
04 Tab.Sinarest Phenylephrine 1-0-1 10mg 1/11 – 2/11
05 Syrup Ascoril Terbutaline 1-0-1 2tsp 1/11 – 9/11
06 Tab.Budesonide Budesonide 1-0-1 200mg 1/11 – 3/11
07 Duolin Rotacaps Levosalbutamol +
Ipatropium bromide
1-1-1 100mcg
+ 40mcg
1/11 – 9/11
08 Tab.Pantoprazole Pantoprazole 1-0-1 40mg 4/11 – 9/11

13. GOALS ACHIEVED
• SYMPTHAMATIC RELIEF.
• PATIENT FELT BETTER FROM THE ASSESSED
CONDITION.

14. DRUG INTERACTIONS
1. Levosalbutamol + Phenylephrine
Both increases sympathetic effects
including increased B P and heart rate.
2. Pantoprazole + Budesonide
Pantoprazole decreases the effect
of budesonide by increasing gastric pH.

15. PHARMACIST INTERVENTION
• UTI is untreated
• Polypharmacy

16. PATIENT COUNSELLING
About disease:
• Nature of disease.
• Risk factors.
• Signs and symptoms.
• Complications.
About the medication:
• Take the medicines at the proper prescribed
time.
• Take medications and take proper rest.

17. FOR LIFE STYLE MODIFICATIONS:
Smoking cessation.
Avoid contact with allergens and polluted
environment.
Avoid fermented foods,Diary products.
Avoid oily and fried foods.
Breathing exercise (especially deep breathing)
Defend against infections.
Focus on good nutrients.
Be prepared for emergencies.
• Educate about nebulizing techniques
• Wear mask while going out.
• Maintain humidified temperature in room.